NCT04171557

Brief Summary

The primary aim of the study is to study the relationship between overall bicycling and all-cause mortality and secondarily cardiovascular disease mortality among individuals with diabetes from European countries. A secondary aim will be to study the relation of change in bicycling to all-cause mortality and cardiovascular disease mortality.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
12,848

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 15, 2019

Completed
5 days until next milestone

Study Start

First participant enrolled

November 20, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 21, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2020

Completed
Last Updated

January 2, 2020

Status Verified

December 1, 2019

Enrollment Period

5 months

First QC Date

November 15, 2019

Last Update Submit

December 29, 2019

Conditions

Keywords

ExercisePhysical ActivityBicycling

Outcome Measures

Primary Outcomes (1)

  • All-cause Mortality

    0 (Alive at follow-up) or 1 (Death at follow-up)

    From 0 years and up to 17 years or until death from any cause, whichever comes first.

Secondary Outcomes (1)

  • Cause specific mortality: Cardiovascular

    From 0 years and up to 17 years or until death from any cause, whichever comes first.

Other Outcomes (2)

  • Cause specific mortality: Cardiovascular

    From 4-6 years (second examination) after 0 years (first examination) and up to 12 years or until death from any cause, whichever comes first.

  • All-cause Mortality

    From 4-6 years (second examination) after 0 years (first examination) and up to 12 years or until death from any cause, whichever comes first.

Study Arms (1)

Patients with diabetes at the baseline assessement in EPIC

Self-reported and confirmed diabetes (validated by a second source (at least 1), including repeated self-report, contact with physician, linkage to register later point, intake of diabetes medicine, registration of diabetic chiropody, baseline glycated hemoglobin\>=6.0%, five annual blood glucose measurements or two blood glucose measurements per year for five consecutive years) cases were included in the analyses. No information is available to distinguish between type 1 and type 2 diabetes across the population but type 1 is rare by comparison.

Behavioral: Bicycling

Interventions

BicyclingBEHAVIORAL

Total bicycling is reported in categories of: (0 - reference), (\>0 to \<60), (≤60 to \>150), (≤150 to \< 300) and (≥300) minutes/week

Patients with diabetes at the baseline assessement in EPIC

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

See Statistical Analysis Plan

You may qualify if:

  • Confirmed or self-reported diabetes at first examination

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center for Physical Activity Research, Copenhagen University Hospital

Copenhagen, 2100, Denmark

Location

MeSH Terms

Conditions

Diabetes MellitusMotor Activity

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesBehavior

Study Officials

  • Mathias Ried-Larsen, PhD

    Copenhagen University Hospital, Centre for Physical Activity Research

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
14 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Researcher

Study Record Dates

First Submitted

November 15, 2019

First Posted

November 21, 2019

Study Start

November 20, 2019

Primary Completion

April 30, 2020

Study Completion

April 30, 2020

Last Updated

January 2, 2020

Record last verified: 2019-12

Data Sharing

IPD Sharing
Will not share

Request for individual patient data should be directed to the International Agency for Research on Cancer (IARC) The predefined statistical analyses plan is available (see link)

Locations